ArticleScientific reports2026
In vivo assessment of collagen transdermal absorption in murine and human skin using photoacoustics microscopy.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The therapeutic potential of collagen for transdermal applications has been hindered by its limited penetration efficiency due to its high molecular weight. This study systematically evaluates the transdermal behavior of C3-modified collagen (ICG-C3) in murine, rat, and human skin using photoacoustic imaging (PAI). Dynamic PAI monitoring revealed that ICG-C3 exhibited enhanced penetration (3-fold higher dermal signal intensity than free ICG, P < 0.05) and prolonged retention (a 181.6% longer half-life than unmodified collagen, P < 0.001) in animal models. Human trials further demonstrated that the efficacy of ICG-C3 was dependent on the anatomical site: it achieved a penetration depth of 210 ± 30 μm (P < 0.01) in dorsal skin (characterized by a thick stratum corneum) and it exhibited a reduced signal decay rate to -25% of controls (P < 0.05) in ventral skin (with high sweat gland density). Non-destructive PAI visualized the directional migration of ICG-C3 along skin appendages. Our findings validate the cross-species universality of C3 modification and establish PAI as a robust tool for real-time transdermal analysis, offering critical insights for developing collagen-based therapeutics and advancing photoacoustic imaging in biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.